AInvest★★★★★3-DAY FREE

Catch pre-market movers with AI signals.

Claim Trial
logo

HOOK(Quitar la ciudad)

HOOKIPA Pharma·NASDAQ
--
--(--)

HOOKIPA Pharma (HOOK) Financial Ratios and Key Metrics

View HOOKIPA Pharma (HOOK) financial ratios, including profitability, valuation, solvency, liquidity, operating efficiency, and per-share metrics. Compare annual, quarterly, and TTM data to better understand the company's financial performance.

Currency:USD
Q4'17Dec 2017Q1'18Mar 2018Q2'18Jun 2018Q3'18Sep 2018Q4'18Dec 2018Q1'19Mar 2019Q2'19Jun 2019Q3'19Sep 2019Q4'19Dec 2019Q1'20Mar 2020Q2'20Jun 2020Q3'20Sep 2020Q4'20Dec 2020Q1'21Mar 2021Q2'21Jun 2021Q3'21Sep 2021Q4'21Dec 2021Q1'22Mar 2022Q2'22Jun 2022Q3'22Sep 2022Q4'22Dec 2022Q1'23Mar 2023Q2'23Jun 2023Q3'23Sep 2023Q4'23Dec 2023Q1'24Mar 2024Q2'24Jun 2024Q3'24Sep 2024Q4'24Dec 2024Q1'25Mar 2025
Return on Capital
------------------------------------------------------------
------------------------------------------------------------
------------------------------------------------------------
Profitability
------------100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
-------------241.52%-298.90%-427.78%-394.61%-302.34%-284.47%-272.08%-283.16%-352.38%-379.49%-442.73%-566.40%-683.84%-791.14%-513.40%-473.50%-494.63%-391.18%-485.34%-119.38%-124.45%-121.78%-117.09%-860.18%
-------------204.69%-257.98%-360.38%-333.02%-247.85%-232.61%-225.09%-237.83%-304.07%-339.33%-410.15%-523.53%-632.07%-715.76%-453.96%-414.22%-426.40%-334.01%-403.46%-88.43%-92.85%-86.42%-99.23%-785.15%
-------------205.43%-258.77%-360.38%-333.02%-247.22%-232.01%-225.09%-237.83%-304.07%-339.34%-410.15%-523.54%-632.09%-715.77%-455.58%-416.94%-429.13%-336.12%-405.29%-88.73%-93.16%-86.74%-98.99%-784.01%
-------------241.52%-298.90%-427.78%-394.61%-302.34%-284.47%-272.08%-283.16%-352.38%-379.49%-442.73%-566.40%-683.84%-791.14%-513.40%-473.50%-494.63%-391.18%-485.34%-119.38%-124.45%-121.78%-117.09%-860.18%
-------------228.30%-281.37%-402.09%-369.21%-286.44%-271.06%-250.89%-262.63%-324.30%-348.86%-417.57%-534.77%-648.24%-753.08%-488.13%-451.94%-472.94%-375.71%-467.69%-113.27%-118.47%-115.12%-110.82%-833.42%
-------------287.33%-302.28%-366.19%-288.00%-240.69%-220.32%-212.98%-231.77%-316.26%-365.28%-426.05%-438.36%-489.97%-542.23%-175.55%-175.48%-174.88%-182.48%-306.44%-154.68%-148.53%-135.76%----
Cost Structure
------------263.03%296.54%387.81%355.58%282.43%278.72%279.75%299.33%359.28%386.09%449.12%543.51%634.48%712.21%481.75%456.55%480.83%403.18%429.35%159.96%164.30%153.29%155.89%654.45%
------------78.49%102.36%139.97%139.02%119.90%105.75%92.33%83.83%93.10%93.40%93.61%122.89%149.36%178.93%131.65%116.95%113.79%88.00%92.57%33.21%33.14%38.21%46.02%246.56%
Solvency
0.16----0.300.350.290.190.170.180.200.220.240.170.180.240.240.290.240.230.250.400.490.410.420.440.280.310.350.380.44
------------------------------------------------------------
------------------------------------------------------------
------------------------------------------------------------
------------------------------------------------------------
------------------------------------------------------------
Liquidity
------------------------------------------------------------
17.34----5.304.245.628.6910.538.687.856.355.658.117.624.234.453.695.485.484.984.133.163.643.443.504.503.863.263.273.61
17.34----5.304.245.628.6910.538.687.856.355.658.117.624.234.453.695.485.484.984.133.163.643.443.504.503.863.263.273.61
------------------------------------------------------------
Operating Efficiency
------------------------------------------------------------
------------------------------------------------------------
------------------------------------------------------------
------------------------------------------------------------
Per Share Metrics
------------------------------------------------------------
------------------------------------------------------------
------------------------------------------------------------
------------------------------------------------------------
------------------------------------------------------------